New Generation Calcium Channel Blockers in Hypertensive Treatment. - Wikidata - awgldk - TriplyDB

New Generation Calcium Channel Blockers in Hypertensive Treatment.

New Generation Calcium Channel Blockers in Hypertensive Treatment.

http://www.wikidata.org/entity/Q37381991

about

Excellent tolerance to cilnidipine in hypertensives with amlodipine - induced edema The fourth-generation Calcium channel blocker: cilnidipine.Cilnidipine induced ankle edema.Management of hypertensive crises in the elderly

P2860

Q34326056-28022BC8-730F-4AF9-96E5-D6790DD62D54 Q34658798-C820FF50-65E9-4558-B592-C994330985DE Q41229942-4B2EFE64-0768-4F5B-8BC0-0827609D07C3 Q58570613-BE4F8860-A95C-412B-A9CA-B6B0BF1AF7B5

P2860

New Generation Calcium Channel Blockers in Hypertensive Treatment.

http://www.wikidata.org/entity/Q37381991

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New Generation Calcium Channel Blockers in Hypertensive Treatment.

@en

New Generation Calcium Channel Blockers in Hypertensive Treatment.

@nl

type

label

New Generation Calcium Channel Blockers in Hypertensive Treatment.

@en

New Generation Calcium Channel Blockers in Hypertensive Treatment.

@nl

prefLabel

New Generation Calcium Channel Blockers in Hypertensive Treatment.

@en

New Generation Calcium Channel Blockers in Hypertensive Treatment.

@nl

P1433

Q37381991-8EC7B6BB-2B96-422D-A003-9AD0EDADCB72

P1476

Q37381991-393F7943-7009-4952-AE66-C618C6223CD9

P2093

Q37381991-71885181-FCE6-41D7-AD49-8372EB87BCD8

Q37381991-F933C0BE-03D1-481D-B301-286F83E66612

P2860

Q37381991-04168944-71CE-40C1-BB4C-623133169F00

Q37381991-06C20E2F-E2B4-4F2C-AC50-EC5080910658

Q37381991-07F0B138-D476-436E-AFF7-24E00E7E628B

Q37381991-0AF9B074-E7E1-4F76-8C26-8942CD8A5944

Q37381991-0D9E2BAD-8F15-475A-8046-1717A3C2474F

Q37381991-0E318007-ACAC-4D37-B2C4-3F0CD32EF8C9

Q37381991-16A4B9B9-B988-49E4-B29D-E78321ADB283

Q37381991-1EB24C33-A6FC-41E8-9650-F119EB25740E

Q37381991-20B68F53-C464-4516-9A7C-A26B6D149ADC

Q37381991-262E1FA4-8D88-45CC-9960-45FB9B7DAE91

P304

Q37381991-B1115A80-8355-41B0-8B8A-BDEC0590FA8E

P31

Q37381991-0A103F83-9B18-4A11-8A8D-BD9C26450AC6

P356

Q37381991-B9FF293C-8104-40AC-A35B-18DA8BF060BE

P433

Q37381991-4F9B703D-D775-4B85-B81D-80A13A2C1527

P478

Q37381991-6FC61669-1E86-4A85-AD82-822FF53E47BC

P50

Q37381991-09FCE042-593F-4068-A4F4-888042557EFB

P577

Q37381991-29B01F0F-6862-4027-8855-761CF2BBAE7B

P5875

Q37381991-2C1D02E0-795F-44AC-88A5-926E9C48DCB9

P698

Q37381991-EF966FCB-07B4-4D86-AC58-E23398AEC700

P932

Q37381991-CEEA810C-6A34-4B1C-AB3A-BAE884F0CECF

P356

157340206776877370

P1433

Current Hypertension Reviews

P1476

New Generation Calcium Channel Blockers in Hypertensive Treatment.

@en

P2093

Koichi Hayashi

http://www.w3.org/2001/XMLSchema#string

Yuri Ozawa

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix

Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels

Blood pressure, stroke, and coronary heart disease

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle.

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Effects of a dual L/N-type Ca(2+) channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs.

P304

103-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/157340206776877370

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Hiroyuki Kobori

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26889248

http://www.w3.org/2001/XMLSchema#string

P698

19823601

http://www.w3.org/2001/XMLSchema#string

P932

2759764

http://www.w3.org/2001/XMLSchema#string